“…As summarized in Table 2, besides collagens, several other ECM molecules are also targeted by glucocorticoids. These include elastin (Del Monaco et al, 1997); proteoglycans decorin and biglycan (Kähä ri et al, 1995); hyaluronan (Saarni and Hopsu-Havu, 1978); noncollagenous glycoproteins, particularly fibronectin, laminin, (Stahn et al, 2007) Modulation of the expression of various types of collagen (Oikarinen et al, 1987;Russell et al, 1989;Oishi et al, 2002), elastin (Del Monaco et al, 1997), proteoglycans decorin and biglycan (Kähäri et al, 1995), HA (Saarni and Hopsu-Havu, 1978), and various noncollagenous matrix glycoproteins such as fibronectin, laminin, and tenascin (Dean et al, 1988;Simo et al, 1992;Ekblom et al, 1993); suppression of MMP synthesis and activity (DiBattista et al, 1991;Sadowski and Steinmeyer, 2001); influence on TIMP expression and activity (Sadowski and Steinmeyer, 2001) NSAIDs e.g., indomethacin, diclofenac, naproxen, and -coxibs such as celecoxib…”